Naito Yukiko, Tago Kazumi, Nagata Tomoko, Furuya Mami, Seki Takayuki, Kato Hiroyasu, Morimura Tomomi, Ohara Naoki
Safety Testing Laboratory, Hatano Research Institute, Food and Drug Safety Center, Ochiai 729-5, Hadano, Kanagawa 257-8523, Japan.
Food Chem Toxicol. 2007 Sep;45(9):1575-87. doi: 10.1016/j.fct.2007.02.018. Epub 2007 Feb 21.
A 90-day ad libitum administration toxicity study of oligoglucosamine (OG) was carried out using F344 rats of both sexes. The animals were divided into four groups of 20 animals each, 10 of each sex, and fed a diet containing 0, 0.04, 0.2 or 1.0 (w/w)% OG. During the administration period, no animals of either sex died or exhibited abnormal signs in the 0.04% OG and 0.2% OG groups. In the 1% OG group, in both sexes, erythema and swelling of the snout and forelimbs and loss of fur in the forelimbs were observed. On macroscopic observation, emaciation, swelling of the snout, auricles and forelimbs and alopecia of the forelimbs were also observed in 2-3 males of the 1% OG group. It was suggested that these topical abnormalities might be due to dermal responses to OG adhering to the skin and fur, which are easily soiled with saliva during grooming. In the animals of the 1% OG group, food consumption decreased, resulting in body weight gain being suppressed. This was found concomitantly with the abnormal findings mentioned above. Thus, feeding difficulties due to the topical lesions on the snout and forelimbs were thought to affect body weight. In hematology, platelet count, lymphocyte count and differential neutrophil count increased in males of the 1% OG group. These changes might be related to the dermal inflammation. Abnormalities in urinalysis and blood chemistry, as well as a small thymus, small spleen, dark spots or areas on the glandular stomach mucosa, pale Harderian glands and small testes in histopathology, were also observed in males in the 1% OG group. Whether or not all these changes were related only to the malnutrition remains to be elucidated. From these results, OG gave rise to no adverse effects in rats up to the dose level of 0.2 (w/w)%. Thus, the no observed adverse effect level was determined to be 0.2 (w/w)% for rats of either sex (124.0mg/kg/day in males, 142.0mg/kg/day in females).
使用F344大鼠对低聚葡萄糖(OG)进行了为期90天的随意给药毒性研究。将动物分为四组,每组20只动物,雌雄各10只,分别喂食含0、0.04、0.2或1.0(w/w)%OG的饲料。在给药期间,0.04%OG组和0.2%OG组的雌雄动物均无死亡或出现异常体征。在1%OG组中,雌雄动物均观察到口鼻部和前肢红斑、肿胀以及前肢脱毛。大体观察发现,1%OG组的2 - 3只雄性动物出现消瘦、口鼻部、耳廓和前肢肿胀以及前肢脱毛。提示这些局部异常可能是由于OG附着于皮肤和毛发,在梳理过程中易被唾液污染,从而引起皮肤反应。在1%OG组动物中,食物摄入量减少,导致体重增加受到抑制。这与上述异常发现同时出现。因此,认为口鼻部和前肢的局部损伤导致的进食困难影响了体重。血液学方面,1%OG组雄性动物的血小板计数、淋巴细胞计数和中性粒细胞分类计数增加。这些变化可能与皮肤炎症有关。1%OG组雄性动物在尿液分析、血液生化方面也出现异常,组织病理学检查还发现胸腺小、脾脏小、腺胃黏膜有黑斑或区域、哈德氏腺苍白以及睾丸小。所有这些变化是否仅与营养不良有关仍有待阐明。根据这些结果,在剂量水平达0.2(w/w)%时,OG对大鼠未产生不良影响。因此,确定雌雄大鼠的无观察到不良作用水平均为0.2(w/w)%(雄性为124.0mg/kg/天,雌性为142.0mg/kg/天)。